Aurora Cannabis Stock Today

ACB Stock  CAD 6.15  0.27  4.59%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Over 84

 
High
 
Low
Very High
Aurora Cannabis is selling at 6.15 as of the 21st of December 2024; that is 4.59 percent increase since the beginning of the trading day. The stock's open price was 5.88. Aurora Cannabis has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 1st of January 2023 and ending today, the 21st of December 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
Category
Healthcare
Classification
Health Care
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. The companys adult-use brand portfolio includes Aurora Drift, San Rafael 71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7 and medical cannabis brands include MedReleaf, CanniMed, Aurora, and WMMC. The company has 54.88 M outstanding shares of which 865.23 K shares are presently shorted by private and institutional investors with about 1.78 days to cover all short positions. More on Aurora Cannabis

Moving against Aurora Stock

  0.9ERE-UN European Residential RealPairCorr
  0.84FFH Fairfax FinancialPairCorr
  0.84Y Yellow Pages LimitedPairCorr
  0.83FFH-PC Fairfax Fin HldPairCorr
  0.82NICU Magna MiningPairCorr
  0.79LB Laurentian BankPairCorr

Aurora Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Aurora Cannabis' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Aurora Cannabis or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ChairmanMichael Singer
Business ConcentrationPharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors)
Aurora Cannabis' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Aurora Cannabis' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Debt Levels
Aurora Cannabis can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Aurora Cannabis' financial leverage. It provides some insight into what part of Aurora Cannabis' total assets is financed by creditors.
Liquidity
Aurora Cannabis cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. Aurora Cannabis has accumulated 104.79 M in total debt with debt to equity ratio (D/E) of 0.41, which is about average as compared to similar companies. Aurora Cannabis has a current ratio of 5.03, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Aurora Cannabis until it has trouble settling it off, either with new capital or with free cash flow. So, Aurora Cannabis' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Aurora Cannabis sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Aurora to invest in growth at high rates of return. When we think about Aurora Cannabis' use of debt, we should always consider it together with cash and equity.

Net Income

(62 Million)
Aurora Cannabis (ACB) is traded on Toronto Exchange in Canada and employs 1,073 people. Aurora Cannabis is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 361.64 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aurora Cannabis's market, we take the total number of its shares issued and multiply it by Aurora Cannabis's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Aurora Cannabis operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 54.88 M outstanding shares of which 865.23 K shares are presently shorted by private and institutional investors with about 1.78 days to cover all short positions. Aurora Cannabis has accumulated about 234.94 M in cash with (68.51 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.46.
Check Aurora Cannabis Probability Of Bankruptcy
Ownership Allocation
Aurora Cannabis holds a total of 54.88 Million outstanding shares. Almost 86.71 percent of Aurora Cannabis outstanding shares are held by general public with 13.29 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Aurora Ownership Details

Aurora Cannabis Risk Profiles

Although Aurora Cannabis' alpha and beta are two of the key measurements used to evaluate Aurora Cannabis' performance over the market, the standard measures of volatility play an important role as well.

Aurora Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Aurora Cannabis without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Analyst Advice Now

   

Analyst Advice

Analyst recommendations and target price estimates broken down by several categories
All  Next Launch Module

Aurora Cannabis Corporate Directors

Adam SzwerasIndependent DirectorProfile
Margaret AtkinsIndependent DirectorProfile
Norma BeauchampIndependent DirectorProfile
Ronald FunkLead Independent DirectorProfile
When determining whether Aurora Cannabis offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aurora Cannabis' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aurora Cannabis Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aurora Cannabis Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aurora Cannabis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
To learn how to invest in Aurora Stock, please use our How to Invest in Aurora Cannabis guide.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Please note, there is a significant difference between Aurora Cannabis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aurora Cannabis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aurora Cannabis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.